Funder: Food and Drug Administration

Due Dates: Forecasted; estimated application due date not yet announced

Funding Amounts: Expected 10 awards; award ceiling and total program funding not yet specified

Summary: Supports research advancing medical product development for prevention, diagnosis, mitigation, treatment, or cure of ALS and other rare neurodegenerative diseases in adults and children.

Key Information: This is a forecasted opportunity; details on deadlines and funding amounts will be updated when the official announcement is released.